Successful treatment of synchronous hairy cell leukaemia and diffuse large B cell lymphoma in a patient with severe hypercalcemia and extensive osteolytic lesions
-
Published:2021
Issue:00
Volume:
Page:73-73
-
ISSN:0042-8450
-
Container-title:Vojnosanitetski pregled
-
language:en
-
Short-container-title:VOJNOSANIT PREGL
Author:
Markovic O.1,
Gotic M.1,
Cemerikic V.1,
Divac A.1,
Marisavljevic D.1
Abstract
Introduction: Although secondary malignancies usually occur at different
times after HCL treatment, (simultaneous) occurrence of HCL and other
malignancies at the same time is very rare. Synchronous hairy cell leukemia
(HCL) and diffuse large B cell lymphoma (DLBCL) has not been described so
far. Case report: We report a 62-years old female patient who presented
with intense constitutional symptoms, hypercalcaemia, pancytopenia and
osteolytic destruction of the left shoulder joint. Immunohistochemical
analysis of the bone marrow revealed presence of two populations: a
population of HCL cells and a population of DLBCL cells with the expression
of c-myc and bcl-2 ("double expressor" DLBCL) and high proliferative
activity (Ki-67+cells>90%). FISH analysis showed amplification of the bcl-2
gene. In addition, BRAF V600E mutation was detected. After intensive
treatment with immunochemotherapy, radiotherapy and bisphosphonates patient
achieved complete remission, lasting for more than two years. Conclusion:
As the association of hairy cell leukemia and lymphoma is a very rare,
diagnosis of synchronous occurrence of two lymphoproliferative diseases is
diagnostic and therapeutic challenge. It remains unclear whether DLBC and
HCL are derived from two different malignant clones or DLBCL developed by
transformation of HCL as the result of clonal evolution of B-cell clone.
Publisher
National Library of Serbia
Subject
Pharmacology (medical),General Medicine